72
55
Growth Score
-12 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
623156
Lupagen is a biotech company developing enabled cell and gene therapies.
Nipon Das: CEO and Co-FounderPast Role: The Boston Consulting Group, Principal- David Peritt: Founder and Chief Scientific OfficerPast Role: Sigilon Therapeutics, Chief Technology Officer
About the Company
Lupagen team of engineers and immunologists developed and brought to market revolutionary bedside point-of-care cell therapies. The company developing cell and gene therapy delivery technologies for next-generation CAR-T, gene editing and immunotherapy products based on their patent-pending bedside, closed-loop, point-of-care technology.
